On the stock market since 2014, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
The stock trades 55% below its peak. The market has trimmed its expectations for the company.
Nothing in the current numbers stands out as a strong positive. That, by itself, is worth knowing.
A loss of $1.5M against $0 in annual sales.
The stock sits at $0.14. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
On our five-subject report card, RENEW sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: RENEW is a high-risk stock — not yet profitable, and its future rides on its product catching on.